Published in
Springer, Quality of Life Research, 3(31), p. 645-657, 2021
DOI: 10.1007/s11136-021-02945-8
Links
Tools
Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review
Journal article published in 2021 by
Amélie Anota,
Astrid Pozet 
,
Hervé Lemasson,
Francois-Emery Cotté,
Antoine Falcoz,
Guillaume Eberst,
Guillaume Mouillet,
Stéphane Guerzider,
Émilie Charton,
Virginie Westeel
,
Hervé Lemasson,
Francois-Emery Cotté,
Antoine Falcoz,
Guillaume Eberst,
Guillaume Mouillet,
Stéphane Guerzider,
Émilie Charton,
Virginie Westeel
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 